XPONANCE, INC. - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 225 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
XPONANCE, INC. ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$23,344
-29.3%
26,348
+24.1%
0.00%
-100.0%
Q3 2022$33,000
-19.5%
21,233
+4.7%
0.00%0.0%
Q2 2022$41,000
+24.2%
20,288
+42.9%
0.00%0.0%
Q1 2022$33,000
-49.2%
14,200
+0.8%
0.00%0.0%
Q4 2021$65,000
-35.0%
14,083
+7.8%
0.00%
-50.0%
Q3 2021$100,000
-31.0%
13,068
-12.4%
0.00%
-33.3%
Q2 2021$145,00014,9250.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 15,001$1,4100.00%
KLCM Advisors, Inc. 20,000$1,8800.00%
AlphaMark Advisors, LLC 3,135$00.00%
TRUST CO OF VERMONT 204$190.00%
SlateStone Wealth, LLC 30,866$30.00%
Coppell Advisory Solutions LLC 100$890.00%
Highlander Capital Management, LLC 1,200$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Russell Investments Group, Ltd. 266$250.00%
OGOREK ANTHONY JOSEPH /NY/ /ADV 3,600$00.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders